Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-03-09 @ 1:58 AM
Study NCT ID:
NCT03788967
Status:
COMPLETED
Last Update Posted:
2022-07-25
First Post:
2018-12-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Sponsor:
Spero Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-22
First Submit QC Date:
None
Study First Post Date:
2018-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-13
Results First Submit QC Date:
None
Results First Post Date:
2022-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-07-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-06-27
Last Update Post Date:
2022-07-25
Last Update Post Date Type:
ACTUAL